传染科指南

订阅

MedSci主页 / 所有栏目 / 传染科指南

2020 国际专家共识：COVID-19的多器官床旁即时超声检查

2020-12-24 Crit Care . 2020 Dec 24;24(1):702.

床旁超声

床旁即时超声（PoCUS）是一种快速、便捷、床旁且具有针对性的超声诊断方法，用于解决特定的临床问题。本文由27个国家的60位本领域专家参与了9个话题的讨论、投票，经过了两轮改良的德尔菲调查法并最终形成

中文标题：

2020 国际专家共识：COVID-19的多器官床旁即时超声检查

英文标题：

Multi-organ point-of-care ultrasound for COVID-19 (PoCUS4COVID): international expert consensus

发布机构：

发布日期：

2020-12-24

简要介绍：

床旁即时超声（PoCUS）是一种快速、便捷、床旁且具有针对性的超声诊断方法，用于解决特定的临床问题。本文由27个国家的60位本领域专家参与了9个话题的讨论、投票，经过了两轮改良的德尔菲调查法并最终形成COVID-19的多器官床旁即时超声检查共识。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 国际专家共识：COVID-19的多器官床旁即时超声检查.pdf)] GetToolGuiderByIdResponse(projectId=1, id=74a551c0020686ef, title=2020 国际专家共识：COVID-19的多器官床旁即时超声检查, enTitle=Multi-organ point-of-care ultrasound for COVID-19 (PoCUS4COVID): international expert consensus, guiderFrom=Crit Care . 2020 Dec 24;24(1):702., authorId=0, author=, summary=床旁即时超声（PoCUS）是一种快速、便捷、床旁且具有针对性的超声诊断方法，用于解决特定的临床问题。本文由27个国家的60位本领域专家参与了9个话题的讨论、投票，经过了两轮改良的德尔菲调查法并最终形成, cover=https://img.medsci.cn/2021310/1615388919152_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Thu Dec 24 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>床旁即时超声（PoCUS）是一种快速、便捷、床旁且具有针对性的超声诊断方法，用于解决特定的临床问题。本文由27个国家的60位本领域专家参与了9个话题的讨论、投票，经过了两轮改良的德尔菲调查法并最终形成COVID-19的多器官床旁即时超声检查共识。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=52104, tagName=床旁超声)], categoryList=[CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=38, categoryName=急重症科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=52104, guiderKeyword=床旁超声, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=12647, appHits=75, showAppHits=0, pcHits=484, showPcHits=12572, likes=0, shares=17, comments=5, approvalStatus=1, publishedTime=Thu Mar 11 00:10:14 CST 2021, publishedTimeString=2020-12-24, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Mar 10 23:10:30 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 22:49:05 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 国际专家共识：COVID-19的多器官床旁即时超声检查.pdf)])
2020 国际专家共识：COVID-19的多器官床旁即时超声检查.pdf
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1202796, encodeId=9d4a1202e9671, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200831/fb689c3e816d4a64820d63f72073eef4/29c665e5fc1341a9ae58ecf5b979aef9.jpg, createdBy=7e215414767, createdName=ANNA1, createdTime=Tue Mar 15 16:47:54 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951674, encodeId=3f989516e428, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=475c5473813, createdName=ms1000001690948493, createdTime=Sat Mar 27 18:34:48 CST 2021, time=2021-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958794, encodeId=c37f958e9482, content=好共识！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Apr 20 16:55:40 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948429, encodeId=06029484298b, content=好共识！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Mar 15 18:12:19 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947506, encodeId=f7b094e5062f, content=得得, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Ket8m6MIibXhvbjRGgD0H2QkkxMsABMZJJejJzbrE7vj81PFX7Ywct0bbjqz6QVK1y0xFGibylE59nWbjZddGNIg/132, createdBy=74df5244281, createdName=Chen chen1547, createdTime=Thu Mar 11 22:03:49 CST 2021, time=2021-03-11, status=1, ipAttribution=)]
    2022-03-15 ANNA1

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1202796, encodeId=9d4a1202e9671, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200831/fb689c3e816d4a64820d63f72073eef4/29c665e5fc1341a9ae58ecf5b979aef9.jpg, createdBy=7e215414767, createdName=ANNA1, createdTime=Tue Mar 15 16:47:54 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951674, encodeId=3f989516e428, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=475c5473813, createdName=ms1000001690948493, createdTime=Sat Mar 27 18:34:48 CST 2021, time=2021-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958794, encodeId=c37f958e9482, content=好共识！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Apr 20 16:55:40 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948429, encodeId=06029484298b, content=好共识！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Mar 15 18:12:19 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947506, encodeId=f7b094e5062f, content=得得, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Ket8m6MIibXhvbjRGgD0H2QkkxMsABMZJJejJzbrE7vj81PFX7Ywct0bbjqz6QVK1y0xFGibylE59nWbjZddGNIg/132, createdBy=74df5244281, createdName=Chen chen1547, createdTime=Thu Mar 11 22:03:49 CST 2021, time=2021-03-11, status=1, ipAttribution=)]
    2021-03-27 ms1000001690948493

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1202796, encodeId=9d4a1202e9671, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200831/fb689c3e816d4a64820d63f72073eef4/29c665e5fc1341a9ae58ecf5b979aef9.jpg, createdBy=7e215414767, createdName=ANNA1, createdTime=Tue Mar 15 16:47:54 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951674, encodeId=3f989516e428, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=475c5473813, createdName=ms1000001690948493, createdTime=Sat Mar 27 18:34:48 CST 2021, time=2021-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958794, encodeId=c37f958e9482, content=好共识！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Apr 20 16:55:40 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948429, encodeId=06029484298b, content=好共识！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Mar 15 18:12:19 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947506, encodeId=f7b094e5062f, content=得得, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Ket8m6MIibXhvbjRGgD0H2QkkxMsABMZJJejJzbrE7vj81PFX7Ywct0bbjqz6QVK1y0xFGibylE59nWbjZddGNIg/132, createdBy=74df5244281, createdName=Chen chen1547, createdTime=Thu Mar 11 22:03:49 CST 2021, time=2021-03-11, status=1, ipAttribution=)]
    2021-04-20 jyzxjiangqin

    好共识！

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1202796, encodeId=9d4a1202e9671, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200831/fb689c3e816d4a64820d63f72073eef4/29c665e5fc1341a9ae58ecf5b979aef9.jpg, createdBy=7e215414767, createdName=ANNA1, createdTime=Tue Mar 15 16:47:54 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951674, encodeId=3f989516e428, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=475c5473813, createdName=ms1000001690948493, createdTime=Sat Mar 27 18:34:48 CST 2021, time=2021-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958794, encodeId=c37f958e9482, content=好共识！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Apr 20 16:55:40 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948429, encodeId=06029484298b, content=好共识！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Mar 15 18:12:19 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947506, encodeId=f7b094e5062f, content=得得, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Ket8m6MIibXhvbjRGgD0H2QkkxMsABMZJJejJzbrE7vj81PFX7Ywct0bbjqz6QVK1y0xFGibylE59nWbjZddGNIg/132, createdBy=74df5244281, createdName=Chen chen1547, createdTime=Thu Mar 11 22:03:49 CST 2021, time=2021-03-11, status=1, ipAttribution=)]
    2021-03-15 jyzxjiangqin

    好共识！

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1202796, encodeId=9d4a1202e9671, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200831/fb689c3e816d4a64820d63f72073eef4/29c665e5fc1341a9ae58ecf5b979aef9.jpg, createdBy=7e215414767, createdName=ANNA1, createdTime=Tue Mar 15 16:47:54 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951674, encodeId=3f989516e428, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=475c5473813, createdName=ms1000001690948493, createdTime=Sat Mar 27 18:34:48 CST 2021, time=2021-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958794, encodeId=c37f958e9482, content=好共识！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Tue Apr 20 16:55:40 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948429, encodeId=06029484298b, content=好共识！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon Mar 15 18:12:19 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947506, encodeId=f7b094e5062f, content=得得, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Ket8m6MIibXhvbjRGgD0H2QkkxMsABMZJJejJzbrE7vj81PFX7Ywct0bbjqz6QVK1y0xFGibylE59nWbjZddGNIg/132, createdBy=74df5244281, createdName=Chen chen1547, createdTime=Thu Mar 11 22:03:49 CST 2021, time=2021-03-11, status=1, ipAttribution=)]
    2021-03-11 Chen chen1547

    得得

    0

拓展阅读

成人重症患者床旁超声引导鼻肠管置入的证据总结

中国医学科学院北京协和医院重症医学科 · 2023-04-20